Why Choosing Sitero for your IRB Services?
Where Ethics Meets Efficiency—Your IRB Advantage

Sitero IRB Technology & Differentiators
Tech-Enabled Tracking
Our platform gives you real-time visibility into the review process, so you’re never left in the dark.
Hands-On Accessibility
You work with the same dedicated team throughout the process.
Transparent Oversight
Easily monitor status, feedback, and approvals within our integrated portal—no more chasing down updates.
Rapid Reviews
Our nimble, white-glove process can cut IRB timelines by up to 40%
Sitero’s Institutional Review Board
Sitero IRB Members Reappointed for 2 Years With 0.0% Turnover!

Sitero IRB Key Metrics
10+ STUDIES | SINGLE POINT OF CONTACT | FULL AAHRPP ACCREDITATION | 450+ SITES
Sitero’s Mentor Innovative Technology

Commitment to Quality & Compliance
Sitero is committed to running a high-quality and compliant IRB service organization

Sitero holds certification in both ISO 27001 and 9001

Sitero holds certification in both ISO 27001 and 9001

Sitero holds an FWA and is registered with NIH OHRP
Testimonial
“Our team has been impressed with the eConsent platform—it’s intuitive, easy to implement, and has improved participant comprehension. The multimedia tools helped simplify complex study details, leading to faster enrollments and stronger engagement. It’s also streamlined our compliance process and boosted confidence in our consent records.”
Director of Clinical Operations
IRB Resources
Learn more about digital consent trends and best practices. Explore our latest blog posts and check back soon for new insights.
Autologous products change hands four times before infusion. Learn where biosafety gaps form between vendors and how to close them before first patient.
Not all CNS assessments can be decentralized. Here is how to identify which hybrid elements work for Parkinson's, Alzheimer's, and MS before protocol lock.
Real-time visibility into ARIA, suicidality, and CNS AEs is not optional. Here is what connected safety monitoring requires for CNS-active compounds.



